Chikungunya virus is spread to people by the bite of an infected mosquito. It can cause fever, headache, muscle pain, fatigue and joint pain. According to the Center for Disease Control, outbreaks have occurred in countries in Africa, Asia, Europe, Latin America and the Indian and Pacific Oceans as well as Latin America. Much like the coronavirus, there is a risk that the chikungunya virus will be imported to new areas by infected travelers. Currently, there is no FDA-approved vaccine to prevent or medicine to treat chikungunya.
The purpose of the study is to evaluate the safety and effectiveness of an investigational Chikungunya vaccine.
- Participants over 18 years of age
- Participants who are healthy adults
- Must meet other study criteria
If Qualified and you participate you will receive:
- All study-related medical exams, lab tests, investigational medication or placebo at no cost.
- Compensation up to $1225 is available for your time and travel
- Insurance is not required.
Take the next step, call us at (757) 627-6798 and ask for the enrollment team, better yet, fill out the brief contact form, and we will call you! This will help us determine if you meet some of the initial criteria necessary to participate. We will contact you within 48 hours to follow-up and clarify any questions that you, or we, may have. The information you provide is entered in our secure, password protected database which can only be accessed by authorized AMR Norfolk personnel, unless given your permission or except as required by law. Provided information will only be used to contact you to tell you more about this and any future study. Your contact information will remain within our database indefinitely unless otherwise requested.